<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Belgium</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Belgium.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/be.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Timing of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128953-24484f5e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128953-24484f5e/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The results validate existing protocols recommending immunization within the specified mid-pregnancy timeframe while demonstrating operational flexibility for clinical scheduling.</description>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Synergy between HA cleavage site sequence and NA-mediated plasminogen recruitment as a virulence mechanism for low-pathogenic avian influenza.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-mbio-02466-25-1e0a83d4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-mbio-02466-25-1e0a83d4/</guid>
    <pubDate>Thu, 26 Feb 2026 00:00:00 GMT</pubDate>
    <description>Characterizing these protein interactions establishes a molecular baseline for evaluating the threat level of emerging avian influenza variants. Such insights may strengthen predictive modeling efforts aimed at safeguarding commercial poultry operations from sudden pathogenic shifts.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</guid>
    <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
    <description>The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>First detection of West Nile virus in Belgium through wild bird surveillance, Belgium, 2025</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-4-2600049-980ed3a5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-4-2600049-980ed3a5/</guid>
    <pubDate>Thu, 29 Jan 2026 00:00:00 GMT</pubDate>
    <description>The detections confirm local West Nile virus circulation in Belgium for the first time and have implications for animal and public health preparedness and surveillance planning for the 2026 mosquito season.</description>
    <category>West Nile virus</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2024-107132-f6683eae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2024-107132-f6683eae/</guid>
    <pubDate>Sun, 01 Sep 2024 00:00:00 GMT</pubDate>
    <description>Understanding which factors contributed to the waning of the 2022 mpox epidemic can inform outbreak response strategies and help anticipate future transmission dynamics in similar settings.</description>
    <category>Monkeypox</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Failure of artemether-lumefantrine therapy in travellers returning to Belgium with Plasmodium falciparum malaria: an observational case series with genomic analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad165-e49d6c94/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad165-e49d6c94/</guid>
    <pubDate>Fri, 29 Dec 2023 00:00:00 GMT</pubDate>
    <description>The findings identify treatment-failure cases among travellers returning from sub-Saharan Africa and describe genomic resistance markers detected in those cases. The authors state that systematic genomic monitoring among international travellers with P. falciparum malaria, particularly after treatment failure, is needed.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Travel medicine</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0264-410x-98-00392-2-6f364c55/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0264-410x-98-00392-2-6f364c55/</guid>
    <pubDate>Mon, 01 Mar 1999 00:00:00 GMT</pubDate>
    <description>The observed antigenic divergence between circulating swine H3N2 viruses and existing vaccine strains highlights the importance of matching veterinary vaccines to currently circulating strains to maintain effective protection in pig populations.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Outbreak investigation</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
</channel>
</rss>
